We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Transcription Regulation Depends on Release from Chromatin

By LabMedica International staff writers
Posted on 09 May 2018
Print article
Image: The long non-coding RNA called A-ROD is only functional the moment it is released from chromatin into the nucleoplasm. At this transient phase, it can bring transcription factors to specific sites in DNA to enhance gene expression. After its complete release from chromatin, A-ROD is no longer active (Photo courtesy of Evgenia Ntini, Max Planck Institute for Molecular Genetics).
Image: The long non-coding RNA called A-ROD is only functional the moment it is released from chromatin into the nucleoplasm. At this transient phase, it can bring transcription factors to specific sites in DNA to enhance gene expression. After its complete release from chromatin, A-ROD is no longer active (Photo courtesy of Evgenia Ntini, Max Planck Institute for Molecular Genetics).
A team of German genome researchers has demonstrated that release from chromatin is a crucial functional aspect of long noncoding RNAs in transcription regulation of their target genes.

Long non-coding RNAs (lncRNAs) are considered to be non-protein coding transcripts longer than 200 nucleotides. This somewhat arbitrary limit distinguishes lncRNAs from small regulatory RNAs such as microRNAs (miRNAs), short interfering RNAs (siRNAs), Piwi-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), and other short RNAs. LncRNAs have been found to be involved in numerous biological roles including imprinting, epigenetic gene regulation, cell cycle and apoptosis, and metastasis and prognosis in solid tumors. Most lncRNAs are expressed only in a few cells rather than whole tissues, or they are expressed at very low levels, making them difficult to study. Their name notwithstanding, long non-coding RNAs (lncRNAs) have been found to actually encode synthesis of small polypeptides that can fine-tune the activity of critical cellular components. LncRNAs are often enriched in the nucleus and at chromatin, but whether their dissociation from chromatin is important for their role in transcription regulation is unclear.

To better understand the link between lncRNAs and chromatin, investigators at the Max Planck Institute for Molecular Genetics (Berlin, Germany) grouped lncRNAs using epigenetic marks, expression, and strength of chromosomal interactions.

They reported in the April 24, 2018, online edition of the journal Nature Communications that lncRNAs transcribed from loci engaged in strong long-range chromosomal interactions were less abundant at chromatin, suggesting the release from chromatin was a crucial functional aspect of lncRNAs in transcription regulation of their target genes.

To gain mechanistic insight into this mechanism, they functionally validated the lncRNA A-ROD, which enhances DKK1 (Dickkopf-related protein 1) transcription via its nascent spliced released form. Detailed validation provided evidence that the regulatory effect was exerted by A-ROD at its release from the chromatin-associated site of transcription.

These findings provide evidence that the regulatory interaction required dissociation of A-ROD from chromatin, with target specificity having been established during the period of chromosomal proximity.

Related Links:
Max Planck Institute for Molecular Genetics

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.